Related Experiment Video
Updated: Jan 25, 2026

Electrocorticographic Recording of Cerebral Cortex Areas Manipulated Using an Adeno-Associated Virus Targeting Cofilin in Mice
Published on: February 21, 2021
Targeting ROCK/LIMK/cofilin signaling pathway in cancer
Mee-Hyun Lee1,2, Joydeb Kumar Kundu3, Jung-Il Chae4
1Basic Medical College, Zhengzhou University, Zhengzhou, 450001, Henan, China.
Abstract:
Rho-associated coiled-coil-containing protein kinase (ROCK)/Lin11, Isl-1 and Mec-3 kinase (LIMK)/cofilin-signaling cascades are stimulated by receptor tyrosine kinases, G protein-coupled receptors, integrins and its ligands, growth factors, hormones, fibronectin, collagen, and laminin. Activated signaling cascades can cause transit from normal cells to cancer cells by modulating actin/filament dynamics. In various cancers including breast, prostate, and colorectal cancers, high expression or activity of each cascade protein is significantly associated with poor survival rate of patients as well as aggressive metastasis. Silencing ROCK, LIMK, or cofilin can abrogate their activities and inhibit cancer cell growth, invasion, and metastasis. Therefore ROCK/LIMK/cofilin signaling proteins might be good candidates to develop cancer prevention strategies or therapeutics. Currently, netarsudil, a ROCK inhibitor, is only used in clinical patients for glaucoma or ocular hypertension, but not for cancer. In this review, we will discuss comprehensive ROCK/LIMK/cofilin signaling pathway in cancers and its inhibitors for developing cancer therapy.
Insights
The Rho-associated coiled-coil-containing protein kinase (ROCK)/LIMK/cofilin pathway drives cancer progression. Inhibiting these signaling proteins may offer new cancer prevention and therapeutic strategies.
Area of Science:
- Oncology
- Molecular Biology
- Cell Signaling
Background:
- The Rho-associated coiled-coil-containing protein kinase (ROCK)/Lin11, Isl-1 and Mec-3 kinase (LIMK)/cofilin signaling pathway is activated by various cellular stimuli.
- This pathway influences actin dynamics, crucial for cell motility and cancer progression.
Purpose of the Study:
- To review the role of the ROCK/LIMK/cofilin signaling pathway in various cancers.
- To explore the potential of targeting this pathway for cancer therapy.
Main Methods:
- Literature review of studies on ROCK/LIMK/cofilin signaling in cancer.
- Analysis of the association between protein expression/activity and patient outcomes.
- Examination of preclinical data on the effects of inhibiting ROCK, LIMK, or cofilin.
Main Results:
- High expression or activity of ROCK, LIMK, or cofilin correlates with poor survival and metastasis in breast, prostate, and colorectal cancers.
- Silencing these proteins inhibits cancer cell growth, invasion, and metastasis.
- Netarsudil, a ROCK inhibitor, is approved for glaucoma but not cancer.
Conclusions:
- The ROCK/LIMK/cofilin pathway is a significant driver of cancer.
- Inhibitors of this pathway represent promising candidates for novel cancer prevention and therapeutic strategies.
More Related Videos
07:42Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays
Published on: September 19, 2018
07:16Monitoring Hippo Signaling Pathway Activity Using a Luciferase-based Large Tumor Suppressor LATS Biosensor
Published on: September 13, 2018
Related Concept Videos
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
Hedgehog Signaling Pathway
Insulin: The Receptor and Signaling Pathways
IP3/DAG Signaling Pathway
Nitric Oxide Signaling Pathway